Ready, an on-demand healthcare service, today announces in-home rapid COVID-19 testing with results in 15 minutes or less. The rapid test can be run from start to finish in the home, increasing the access to widespread testing outside of healthcare facilities. This testing capability not only reduces potential exposure at hospitals or testing sites, but also provides patients with fast and convenient results.
Why Ready’s COVID Test is Different
Ready sends a healthcare professional with the appropriate personal protective equipment directly to a patient’s home or office - no lines, no increased risk of exposure – just fast, private testing.
Ready offers what is known as a Rapid Antigen COVID test, which gives a patient their results in 15 minutes. Many other care providers are administering a PCR test, which must be processed in a lab, and generally takes 2-3 days—sometimes much longer—before patients can see their results. Unfortunately, in the waiting period, there’s potential for exposure to COVID, making the PCR test an unreliable alternative for some patients.
How Ready’s At-home Antigen COVID Test Works
Ready is using the BD Veritor™ System for Rapid Detection of SARS-CoV-2. Antigen tests like this one are designed to detect proteins from the virus that causes COVID in respiratory specimens, such as the specimens found in nasal swabs.
"Receiving the call that you or a family member has been exposed to COVID causes immediate stress and confusion," said Ready Founder and CEO Justin Dangel. "Being able to receive a test at home, receive results immediately eases the stress of that process — all without visiting a hospital or doctor’s office."
Schedule a COVID test online at GetReady.com or call (504) 370-9966.
Some airlines and destinations that require a COVID test will accept our Rapid Antigen Test. Travelers should confirm testing requirements before booking a test for travel purposes.
About Ready (In-Home Urgent Care)
Ready is an on-demand health service that delivers care to its patients in their homes or communities. Ready accomplishes this with a team of highly trained health professionals which we call Responders. During each visit, a Responder provides in-person care. A Responder can also connect the patient to a doctor or nurse practitioner who provides treatment using video conferencing. Ready is a convenient, fast, and affordable solution that reduces overall health costs and delivers more positive outcomes. Investors include GV, Deerfield Management Company, City Light Capital, Town Hall Ventures, and Frist Cressey Ventures, among others.
Ready currently serves patients in New York, Los Angeles, Miami, Washington, D.C., Baltimore, Maryland, Reno, Las Vegas, Nevada, New Orleans, Baton Rouge, Shreveport and Houma, Louisiana.
*The BD Veritor test has been authorized by FDA under an EUA for use by authorized laboratories and has not been cleared or approved by FDA. This test has been authorized only for the detection of proteins from SARS-CoV-2, not for any other viruses or pathogens. This test is only authorized for the duration of the declaration that circumstances exist justifying the authorization of emergency use of in vitro diagnostics for detection and/or diagnosis of COVID-19 under Section 564(b)(1) of the Act, 21 U.S.C. § 360bbb-3(b)(1), unless the authorization is terminated or revoked sooner.
View source version on businesswire.com: https://www.businesswire.com/news/home/20210122005044/en/